Premium
DNA amplification and expression of FADD in oral squamous cell carcinoma
Author(s) -
Prapinjumrune Chanwit,
Morita Keiichi,
Kuribayashi Yuri,
Hanabata Yasuko,
Shi Qi,
Nakajima Yusuke,
Inazawa Johji,
Omura Ken
Publication year - 2010
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.2009.00847.x
Subject(s) - basal cell , fadd , cancer research , dna , carcinoma , biology , medicine , pathology , genetics , apoptosis , programmed cell death , caspase
J Oral Pathol Med (2010) 39 : 525–532 Background: The Fas‐associated death domain‐containing protein, FADD, is an adaptor for relaying apoptotic signals. However, recent studies have shown that FADD also plays an important role in the growth and regulation of the cell cycle. The purpose of this study was to elucidate the role of FADD in oral squamous cell carcinoma (SCC). Methods: The DNA amplification of FADD from 30 samples of tongue SCC was analyzed using real‐time PCR and the protein expression of FADD from 60 samples of tongue SCC was analyzed using immunohistochemistry. Results: The DNA amplifications of FADD were observed in 13 cases (44.3%) and were significantly correlated with the histopathological differentiation grade of SCCs ( P = 0.009). FADD expression levels compared with the matched adjacent epithelium increased significantly ( P = 0.000). Additionally, the positive expressions of FADD were significantly correlated with lymph node metastasis of SCCs ( P = 0.029) and the 5‐year disease‐specific survival rates ( P = 0.049). A positive association between FADD expression level and the histopathological differentiation grade was found to be limited to T1 SCCs ( P = 0.019). DNA amplification was moderately correlated (correlation coefficient = 0.406, P = 0.026) with expression of FADD in 30 samples of tongue SCC. Conclusion: In tongue SCCs, the expression of FADD was higher when compared with that of adjacent areas, which might be determined via genomic amplification in 11q13.3. Thus, SCC cells with the expression of FADD are possibly more likely to become metastatic and to worsen survival rates.